Proteoglycans in Inflammation
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
89-102
Author(s):
M. Delehedde, F. Allain, S. J. Payne, R. Borgo, C. Vanpouille, D. G. Fernig and E. Deudon
5-Lipoxygenase in the Central Nervous System: Therapeutic Implications
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
115-121
Author(s):
Hari Manev and Tolga Uz
IL-4 and IL-13: Their Pathological Roles in Allergic Diseases and their Potential in Developing New Therapies
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
263-269
Author(s):
K. Izuhara, K. Arima and S. Yasunaga
The Use of Leukotriene Modifying Drugs in Asthma and Other Respiratory Diseases
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
271-275
Author(s):
J. A. Corless and M. Paracha
Oxidative Stress and Gene Transcription in Asthma and Chronic Obstructive Pulmonary Disease: Antioxidant Therapeutic Targets
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
291-315
Author(s):
Irfan Rahman
Update on Sensitivity to Nonsteroidal Antiinflammatory Drugs
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
233-240
Author(s):
E. Nettis, M.C. Colanardi, A. Ferrannini and A. Tursi
Therapeutic Applications of Antisense Oligonucleotides in Asthma and Allergy
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
1
Page:
171-175
Author(s):
Maria Isidoro-Garcia and Ignacio Davila
Potential of Lung Surfactant Proteins, SP-A and SP-D, and Mannan Binding Lectin for Therapy and Genetic Predisposition to Allergic and Invasive Aspergillosis
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
1
Page:
183-187
Author(s):
Taruna Madan
Novel Approaches for Inhibition of Mucus Hypersecretion in Asthma
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
1
Page:
188-192
Author(s):
Anurag Agrawal, Ulaganathan Mabalirajan, Arjun Ram and Balaram Ghosh
A Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab) in the Therapy of Moderate-to-Severe Allergic Asthma
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
1
Page:
225-231
Author(s):
D'Amato Gennaro, Piccolo Amedeo, Salzillo Antonello, Noschese Paolo, D'Amato Maria and Liccardi Gennaro